港股異動丨百勝中國(9987.HK)跌近4% 季度經調整經營利潤或跌50%至60% 8月同店銷售同比跌超10%
格隆匯9月15日丨百勝中國(9987.HK)低開低走,現跌近4%,報460港元,總市值1934億港元。百勝中國公佈,受Delta變異毒株的疫情影響,公司運營受到不利影響。百勝中國指,按照當前趨勢,預計第三季度不計入特別項目的經調整經營利潤或同比下降約50至60%,主要是由於收入大幅減少對銷售槓桿產生影響所致。而8月同店銷售額同比下降十幾個百分點,若相對2019年8月,則下降約 20%,主要是由於堂食的同店銷售額同比下降約20%至30%,以及交通樞紐和旅遊景點的同店銷售額同比大幅下降約40%至50%所致。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.